Haoxi Health Technology Limited (NASDAQ:HAO) Sees Large Decline in Short Interest

Haoxi Health Technology Limited (NASDAQ:HAO) was the target of a large drop in short interest in July. As of July 31st, there was short interest totaling 140,665 shares, a drop of 74.2% from the July 15th total of 544,897 shares. Based on an average daily trading volume, of 4,482,278 shares, the short-interest ratio is presently 0.0 days. Currently, 1.9% of the company’s stock are sold short.

Haoxi Health Technology Stock Performance

Shares of HAO traded up $0.00 during mid-day trading on Thursday, hitting $0.16. 1,848,997 shares of the company traded hands, compared to its average volume of 2,482,592. The business has a 50 day moving average of $0.65 and a 200 day moving average of $76.67. Haoxi Health Technology has a 1-year low of $0.14 and a 1-year high of $285.44.

Haoxi Health Technology shares are scheduled to reverse split before the market opens on Friday, August 14th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, August 13th.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Haoxi Health Technology in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Haoxi Health Technology presently has an average rating of “Sell”.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.